Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07474857Not ApplicableCompleted

Anti-HLA Antibodies After Bone Regeneration Surgery

Role: lead

NCT07324213Not ApplicableCompleted

Healing of Mandibular Third Molar Extraction Sockets Using Platelet Concentrates and Photobiomodulation

Role: lead

NCT07324187Not ApplicableCompleted

CTG vs VCMX for Peri-implant Soft Tissue Thickness

Role: lead

NCT04072926Early Phase 1Completed

Effects of PDT and Bioceramic Filling on Periapical Healing and Postoperative Pain After Endodontic Retreatment

Role: lead

NCT04243460Not ApplicableCompleted

Influence of Soft Tissue Thickness on the Bone Level Around Implants

Role: lead

All 5 trials loaded